Şunu mu demek istediniz:
notification » certification (Aramayı Genişlet), verification (Aramayı Genişlet)
notifications » certifications (Aramayı Genişlet), verifications (Aramayı Genişlet)
justification » certification (Aramayı Genişlet)
purification » verification (Aramayı Genişlet), publication (Aramayı Genişlet)
notification » certification (Aramayı Genişlet), verification (Aramayı Genişlet)
notifications » certifications (Aramayı Genişlet), verifications (Aramayı Genişlet)
justification » certification (Aramayı Genişlet)
purification » verification (Aramayı Genişlet), publication (Aramayı Genişlet)
-
281
Total Synthesis of Rohitukine and Dysoline and Their Anticancer Analogues Flavopiridol and IIIM-290
Baskı/Yayın Bilgisi 2025Konular: -
282
Total Synthesis of Rohitukine and Dysoline and Their Anticancer Analogues Flavopiridol and IIIM-290
Baskı/Yayın Bilgisi 2025Konular: -
283
Additional file 4 of MOADE: a multimodal autoencoder for dissociating bulk multi-omics data
Baskı/Yayın Bilgisi 2025Konular: -
284
Additional file 3 of MOADE: a multimodal autoencoder for dissociating bulk multi-omics data
Baskı/Yayın Bilgisi 2025Konular: -
285
Additional file 1 of MOADE: a multimodal autoencoder for dissociating bulk multi-omics data
Baskı/Yayın Bilgisi 2025Konular: -
286
Supplementary Material for: Current Knowledge on the Impact of Extracorporeal Blood Purification Devices on Drug Clearance – Systematic Search & Narrative Review
Baskı/Yayın Bilgisi 2025“…Introduction Extracorporeal blood purification (EBP) devices are increasingly used in critically ill patients to manage sepsis, hyperinflammatory states, and other life-threatening conditions. …”
-
287
Purification of rAAV vectors using scalable AAVX-based affinity chromatography workflow and assessment of intracerebral delivery routes.
Baskı/Yayın Bilgisi 2025“…<p><b>(A)</b> Cartoon depicting HYPERFlask and AAVX-based affinity chromatography method for the production and purification of high-titer rAAV9 vector preparations. …”
-
288
-
289
One-Step Labeling and Purification: Accelerating FAHFA Detection in Vegetable Oils via Chemoselective Probe-Assisted LC–MS
Baskı/Yayın Bilgisi 2025“…The probe enabled single-batch sample pretreatment within 30 min, integrating capture, purification, and signal amplification. Coupled with liquid chromatography–mass spectrometry, the method achieved high sensitivity (LOD: 0.0039–0.033 ng/mL) and enabled quantification of 47 FAHFA isomers in 47 vegetable oil samples, with concentrations ranging from 0.56 to 1.76 × 10<sup>4</sup> ng/g. …”
-
290
Purification of SUMO-PRV peptide AB E10A/E13A/D15A mutant.
Baskı/Yayın Bilgisi 2025“…<p>(A) Nickel column purification of SUMO-PRV peptide AB E10A/E13A/D15A mutant proteins. …”
-
291
Improved Pharmacokinetic Profiles of HDAC6 Inhibitors via Cap Group Modifications
Baskı/Yayın Bilgisi 2025“…Hydroxamic acid (HA)-based HDAC inhibitors often suffer from poor pharmacokinetic (PK) profiles, limiting their in vivo applications. Cap group modification offers a promising strategy to address these challenges. …”
-
292
Improved Pharmacokinetic Profiles of HDAC6 Inhibitors via Cap Group Modifications
Baskı/Yayın Bilgisi 2025“…Hydroxamic acid (HA)-based HDAC inhibitors often suffer from poor pharmacokinetic (PK) profiles, limiting their in vivo applications. Cap group modification offers a promising strategy to address these challenges. …”
-
293
Research Progress on Histone Lactylation Modification in Ischemic Stroke: Mechanisms and Therapeutic Potential
Baskı/Yayın Bilgisi 2025Konular: “…Histone lactylation modification…”
-
294
<b>Lossless Altered Histone Modification Analysis System (LAHMAS)</b>m
Baskı/Yayın Bilgisi 2025“…The resultant Lossless Altered Histone Modification Analysis System (LAHMAS) employs a PDMS-silane treated glass surface immersed in silicone oil to facilitate lossless liquid handling and prevent sample evaporation. …”
-
295
Modification map illustrating the three-point force system for correcting pronation of the foot.
Baskı/Yayın Bilgisi 2025Konular: -
296
Summary of Substituted Cysteine Modification and Anesthetic Protection Studies in α1 Subunits.
Baskı/Yayın Bilgisi 2025Konular: -
297
Genetic modifications of Ad11 for tumor-selectivity and evaluation of tumor-selective replication.
Baskı/Yayın Bilgisi 2025 -
298
Summary of Substituted Cysteine Modification and Anesthetic Protection Studies in β3 Subunits.
Baskı/Yayın Bilgisi 2025Konular: -
299
-
300
Characteristics of the interventions: tailoring, modification, how well (planned) and how well (actual).
Baskı/Yayın Bilgisi 2025“…<p>Characteristics of the interventions: tailoring, modification, how well (planned) and how well (actual).…”